We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

42 hedge funds and large institutions have $116M invested in Axcella Health Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less capital invested

Capital invested by funds: $138M → $116M (-$22.1M)

18% less funds holding

Funds holding: 5142 (-9)

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders
42
Holders Change
-9
Holders Change %
-17.65%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
3
Increased
23
Reduced
10
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$59K
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$59K +$3.57K +29 +6%
TRCT
28
Tower Research Capital (TRC)
New York
$55K +$48.4K +393 +479%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$51K
HighTower Advisors
30
HighTower Advisors
Illinois
$46K +$49.3K +400 New
Bank of America
31
Bank of America
North Carolina
$44K +$24.4K +198 +109%
AIG
32
American International Group
New York
$42K +$15.5K +126 +54%
Deutsche Bank
33
Deutsche Bank
Germany
$38K +$15.4K +125 +61%
Barclays
34
Barclays
United Kingdom
$31K +$7.39K +60 +28%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$14.8K +$14.3K +116 +967%
Legal & General Group
36
Legal & General Group
United Kingdom
$8K +$1.11K +9 +14%
UBS Group
37
UBS Group
Switzerland
$6K -$8.63K -70 -56%
Citigroup
38
Citigroup
New York
$3K -$2.46K -20 -41%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$3K -$493 -4 -13%
AIP
40
Ameritas Investment Partners
Nebraska
$1K
Millennium Management
41
Millennium Management
New York
$132 -$101K -820 -42%
MIM
42
Monashee Investment Management
Massachusetts
-$1.24M -9,000 Closed
EI
43
EAM Investors
California
-$502K -3,628 Closed
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
-$148K -1,068 Closed
Goldman Sachs
45
Goldman Sachs
New York
-$138K -998 Closed
VF
46
Virtu Financial
New York
-$120K -871 Closed
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
-$70K -508 Closed
Two Sigma Advisers
48
Two Sigma Advisers
New York
-$61K -440 Closed
OIA
49
Optimum Investment Advisors
Illinois
-$3K -24 Closed
First Manhattan
50
First Manhattan
New York
-$2K -20 Closed

AXLA Hedge Fund Activity: Q3 2020 in Review

42 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2020, worth a combined $116M — down 16% from $138M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of AXLA and 3 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 23 added.

The largest buyer was BlackRock, adding an estimated $1.07M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.24M sold.

  • 42 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2020, down from 51 in Q2 2020.
  • Funds reported $116M of Axcella Health Inc. Common Stock stock for Q3 2020, down 16% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q3 2020 and 11 closed out, a net change of -8 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $1.07M added.
  • The largest Axcella Health Inc. Common Stock seller in Q3 2020 was Monashee Investment Management, an estimated $1.24M sold.

Based on aggregated 13F filings for Q3 2020.